P. Olander Medica development AB is a Swedish AB based in Sparsör, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2020, the company has 0 employees.
Solidity ratio Equity ÷ Total assets × 100 2021 2025
Liquidity ratio Current assets ÷ Short-term debt 2021 2025
Return on assets (ROA) Net profit ÷ Total assets × 100 2021 2025
EBITDA — year on year SEK millions 0M 0M 0M -1M -1M 2021: 0M 0M 2021 2022: 0M 0M 2022 2023: 0M 0M 2023 2024: 0M 0M 2024 2025: 0M 0M 2025
Key figures Annual report 2025 Revenue — — EBITDA −0,4 mn kr. -783% Net profit −0 mn kr. -456% Total assets 34 mn kr. +56% Equity 5,1 mn kr. +11534% Employees 0 —
Legal name
P. Olander Medica development AB
Founded
7 January 2020 · 6 years
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att bedriva forskning, utveckling och försäljning av medicinsk utrustning samt därmed förenlig verksamhet.
(no translation available)
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Explore Financial development The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net loss of 27,8 tn kr.
At the end of 2025, equity financed 15.1% of the balance sheet, and current assets covered short-term debt 0.3 times.
Frequently asked questions What is the Org number of P. Olander Medica development AB? P. Olander Medica development AB is registered with Bolagsverket / SCB under Org 5592354301.
Who is the CEO of P. Olander Medica development AB? Per Magnus Olander is the CEO of P. Olander Medica development AB, in role since 2022.
Where is P. Olander Medica development AB headquartered? P. Olander Medica development AB's registered address is Sparsörsvägen 1.
More on P. Olander Medica development AB 